Edward Fan

Edward Fan is an experienced finance professional currently serving as the Chief Financial Officer at Clear Labs since June 2022. Prior to this role, Edward held the position of Executive Director in Healthcare Investment Banking at J.P. Morgan, leading transactions such as the sale of Palamedrix to SomaLogic and a $690 million convertible notes offering for Amyris. Edward's career includes significant positions at Lazard as Vice President of Healthcare Investment Banking, where involvement in major deals such as Five Prime's sale to Amgen was notable. Earlier experience at Sanofi and Werfen North America provided expertise in market intelligence and product management. Edward earned both a Master’s and a Bachelor’s degree in Engineering from Tufts University, graduating with high honors.